Monday, May 29, 2017

Oncogenesis - Table of Contents alert Volume 6, May 2017


Open for Submissions

npj Precision Oncology is a new open access, online-only, peer-reviewed journal committed to publishing cutting-edge scientific research in all aspects of precision oncology from basic science to translational applications, to clinical medicine. The journal is part of the Nature Partner Journals series and published in partnership with The Hormel Institute, University of Minnesota.

Explore the benefits of submitting your manuscript.


Volume 6, May 2017

In this issue
Original Articles
Short Communication
Sign up for e-alerts Sign up for e-alerts
Web feed

Original Articles


The zinc-finger transcriptional factor Slug transcriptionally downregulates ERα by recruiting lysine-specific demethylase 1 in human breast cancer

J-W Bai, M-N Chen, X-L Wei, Y-Ch Li, H-Y Lin, M Chen, J-W Li, C-W Du, K Man and G-J Zhang

Oncogenesis 2017 6: e330; 10.1038/oncsis.2017.38

Abstract | Full Text

Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma

J-Y Chuang, W-L Lo, C-Y Ko, S-Y Chou, R-M Chen, K-Y Chang, J-J Hung, W-C Su, W-C Chang and T-I Hsu

Oncogenesis 2017 6: e339; 10.1038/oncsis.2017.31

Abstract | Full Text

Membrane-bound β-catenin degradation is enhanced by ETS2-mediated Siah1 induction in Helicobacter pylori-infected gastric cancer cells

L Das, S B Kokate, P Dixit, S Rath, N Rout, S P Singh, S E Crowe and A Bhattacharyya

Oncogenesis 2017 6: e327; 10.1038/oncsis.2017.26

Abstract | Full Text

Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma

S A Greenall, Y C Lim, C B Mitchell, K S Ensbey, B W Stringer, A L Wilding, G M O'Neill, K L McDonald, D J Gough, B W Day and T G Johns

Oncogenesis 2017 6: e336; 10.1038/oncsis.2017.33

Abstract | Full Text

MicroRNA-645 is an oncogenic regulator in colon cancer

S T Guo, X Y Guo, J Wang, C Y Wang, R H Yang, F H Wang, X Y Li, H Hondermarck, R F Thorne, Y F Wang, L Jin, X D Zhang and C C Jiang

Oncogenesis 2017 6: e335; 10.1038/oncsis.2017.37

Abstract | Full Text

The prohibitin-repressive interaction with E2F1 is rapidly inhibited by androgen signalling in prostate cancer cells

S Koushyar, G Economides, S Zaat, W Jiang, C L Bevan and D A Dart

Oncogenesis 2017 6: e333; 10.1038/oncsis.2017.32

Abstract | Full Text

TRPV4 plays a role in breast cancer cell migration via Ca2+-dependent activation of AKT and downregulation of E-cadherin cell cortex protein

W H Lee, L Y Choong, T H Jin, N N Mon, S Chong, C S Liew, T Putti, S Y Lu, C Harteneck and Y P Lim

Oncogenesis 2017 6: e338; 10.1038/oncsis.2017.39

Abstract | Full Text

Epigenetic pathway inhibitors represent potential drugs for treating pancreatic and bronchial neuroendocrine tumors

K E Lines, M Stevenson, P Filippakopoulos, S Müller, H E Lockstone, B Wright, S Grozinsky-Glasberg, A B Grossman, S Knapp, D Buck, C Bountra and R V Thakker

Oncogenesis 2017 6: e332; 10.1038/oncsis.2017.30

Abstract | Full Text

Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditions

S Murai, A Ando, S Ebara, M Hirayama, Y Satomi and T Hara

Oncogenesis 2017 6: e329; 10.1038/oncsis.2017.34

Abstract | Full Text

Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth

H J Nakaoka, Z Tanei, T Hara, J S Weng, A Kanamori, T Hayashi, H Sato, A Orimo, K Otsuji, K Tada, T Morikawa, T Sasaki, M Fukayama, M Seiki, Y Murakami and T Sakamoto

Oncogenesis 2017 6: e334; 10.1038/oncsis.2017.27

Abstract | Full Text

The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling

G Nappo, F Handle, F R Santer, R V McNeill, R I Seed, A T Collins, G Morrone, Z Culig, N J Maitland and H H H Erb

Oncogenesis 2017 6: e342; 10.1038/oncsis.2017.23

Abstract | Full Text

Regulation of miR-483-3p by the O-linked N-acetylglucosamine transferase links chemosensitivity to glucose metabolism in liver cancer cells

F Pepe, S Pagotto, S Soliman, C Rossi, P Lanuti, C Braconi, R Mariani-Costantini, R Visone and A Veronese

Oncogenesis 2017 6: e328; 10.1038/oncsis.2017.35

Abstract | Full Text

AKT is indispensable for coordinating Par-4/JNK cross talk in p21 downmodulation during ER stress

R U Rasool, D Nayak, S Chakraborty, M M Faheem, B Rah, P Mahajan, V Gopinath, A Katoch, Z Iqra, S K Yousuf, D Mukherjee, L D Kumar, A Nargotra and A Goswami

Oncogenesis 2017 6: e341; 10.1038/oncsis.2017.41

Abstract | Full Text

CCN5/WISP-2 restores ER- in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen

S Sarkar, A Ghosh, S Banerjee, G Maity, A Das, M A Larson, V Gupta, I Haque, O Tawfik and S K Banerjee

Oncogenesis 2017 6: e340; 10.1038/oncsis.2017.43

Abstract | Full Text

miRNA-34c-5p inhibits amphiregulin-induced ovarian cancer stemness and drug resistance via downregulation of the AREG-EGFR-ERK pathway

S-L Tung, W-C Huang, F-C Hsu, Z-P Yang, T-H Jang, J-W Chang, C-M Chuang, C-R Lai and L-H Wang

Oncogenesis 2017 6: e326; 10.1038/oncsis.2017.25

Abstract | Full Text

CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients

C Windmüller, D Zech, S Avril, M Boxberg, T Dawidek, B Schmalfeldt, M Schmitt, M Kiechle and H Bronger

Oncogenesis 2017 6: e331; 10.1038/oncsis.2017.29

Abstract | Full Text

Metformin inhibits SUV39H1-mediated migration of prostate cancer cells

T Yu, C Wang, J Yang, Y Guo, Y Wu and X Li

Oncogenesis 2017 6: e324; 10.1038/oncsis.2017.28

Abstract | Full Text

α2,6-Sialylation mediates hepatocellular carcinoma growth in vitro and in vivo by targeting the Wnt/β-catenin pathway

Y Zhao, A Wei, H Zhang, X Chen, L Wang, H Zhang, X Yu, Q Yuan, J Zhang and S Wang

Oncogenesis 2017 6: e343; 10.1038/oncsis.2017.40

Abstract | Full Text

Short Communication


Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation

J Xu, N Pfarr, V Endris, E K Mai, N H Md Hanafiah, N Lehners, R Penzel, W Weichert, A D Ho, P Schirmacher, H Goldschmidt, M Andrulis and M S Raab

Oncogenesis 2017 6: e337; 10.1038/oncsis.2017.36

Abstract | Full Text

Advertisement webcasts

Join us for our upcoming webcast followed by live Q&A: 

Presented by BioPharma Dealmakers

Date: Tuesday, 13 June, 2017
Time: 8AM PDT | 11AM EDT | 4PM BST | 5PM CEST


Sponsored by: Immunomic Therapeutics, Inc., | IsoPlexis | Merus N.V. | Actinium Pharmaceuticals, Inc.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogenesis. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: